Genetic analyses of tumours have shown that aberrant phosphatidyl inositol-3 kinase (PI3K) signaling is a critical oncogenic stimulus in many different types of cancer including breast, bladder, prostate, thyroid, ovarian and non-small-cell lung cancer (NSCLC) [1–6]. This evidence concerns the gene PIK3CG and cancer.